Safety of drugs can never be absolute

Current Opinion in Drug Discovery and Development

Volumn 9, Issue 1, 2006, Pages 26-28

  Smith, Dennis A ^a   Johnson, Dale E ^b   Park, B Kevin ^c  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; CERIVASTATIN; CITALOPRAM; CLOMIPRAMINE; CYCLOOXYGENASE 2 INHIBITOR; FLUOXETINE; FLUVOXAMINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMIPRAMINE; MAPROTILINE; MIANSERIN; NATALIZUMAB; NEFAZODONE; PAROXETINE; SERTRALINE; TRASTUZUMAB; TRAZODONE; TROGLITAZONE; VENLAFAXINE; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTINEOPLASTIC AGENT; CHROMAN DERIVATIVE; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; BREAST CANCER; CARDIOTOXICITY; CROHN DISEASE; DIABETES MELLITUS; DRUG APPROVAL; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; EDITORIAL; FOOD AND DRUG ADMINISTRATION; HEART FAILURE; HUMAN; IN VITRO STUDY; LIVER FUNCTION TEST; LIVER TOXICITY; MULTIPLE SCLEROSIS; MUSCLE WEAKNESS; MYOPATHY; NONHUMAN; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RHABDOMYOLYSIS; RISK BENEFIT ANALYSIS; SYSTEMATIC REVIEW; UNITED KINGDOM; UNITED STATES; ANIMAL; DRUG DESIGN; DRUG TOXICITY; HEART DISEASE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CHROMANS; DRUG DESIGN; DRUG TOXICITY; HEART DISEASES; HUMANS; THIAZOLIDINEDIONES;

EID: 30744464371     PISSN: 13676733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (5)

1. Jamal SM: Rhabdomyolysis associated with hydroxymethylglutaryl-coenzyme A reductase inhibitors. Am Heart J (2004) 147(6):956-965.
2. Carvajal Garcia-Pando A, Garcia del Pozo J, Sanchez AS, Velasco MA, Rueda de Castro AM, Lucena MI: Hepatotoxicity associated with the new antidepressants. J Clin Psychiatry (2002) 63(2):135-137.
3. Burstein HJ: The distinctive nature of HER2-postitive breast cancers. N Engl J Med (2005) 353(16):1652-1654.
4. Editorial: Herceptin and early breast cancer: A moment for caution. Lancet (2005) 366(9498):1673.
5. O'Neill PM, Mukhtar A, Stocks PA, Randle LE, Hindley S, Ward SA, Storr RC, Bickley JF, O'Neil IA, Maggs JL, Park BK et al. Isoquine and related amodiaquine analogues: A new generation of improved 4-aminoquinoline antimalarials. J Med Chem (2003) 46(23):4933-4945.